# Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)

> **NCT00237588** · PHASE4 · COMPLETED · sponsor: **Ullevaal University Hospital** · enrollment: 25 (—)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Amlodipine 10 mg or Losartan 100 mg + Amlodipine 5 mg

## Key facts

- **NCT ID:** NCT00237588
- **Lead sponsor:** Ullevaal University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 25 (—)
- **Last updated:** 2011-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00237588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00237588, "Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00237588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*